Question 1

What is Ernexa Therapeutics Inc. Common Stock's WACC?

Accepted Answer

Ernexa Therapeutics Inc. Common Stock (ERNA) has a Weighted Average Cost of Capital (WACC) of 20.00%. This is calculated using a Cost of Equity of 8.49% (via CAPM with a beta of 1.00) and a pre-tax Cost of Debt of 95.97%, with an equity weight of 46.52% in the capital structure.

Question 2

Is Ernexa Therapeutics Inc. Common Stock's WACC high or low?

Accepted Answer

Ernexa Therapeutics Inc. Common Stock's WACC of 20.00% is above the typical range, indicating higher perceived risk and cost of capital. WACC is used as the discount rate in DCF valuations — a lower WACC results in higher present values of future cash flows.

Question 3

How is Ernexa Therapeutics Inc. Common Stock's WACC calculated?

Accepted Answer

Ernexa Therapeutics Inc. Common Stock's WACC is calculated using the formula: WACC = (E/V × Re) + (D/V × Rd × (1-T)). The Cost of Equity (Re) of 8.49% is derived from the CAPM model using a beta of 1.00. The pre-tax Cost of Debt (Rd) is 95.97%. The capital structure is 46.52% equity and 53.48% debt.

Ernexa Therapeutics Inc. Common Stock (ERNA) — WACC 分析

WACC 构成

解读

Ernexa Therapeutics Inc. Common Stock（ERNA）WACC：20.00%

WACC计算器

Ernexa Therapeutics Inc. Common Stock（ERNA） WACC 解读

ERNA 公司分析

ERNA DCF 估值

继续做同行对比